GOOD NEWS! Panlaban sa Coronavirus, natuklasan ng Biotech Company.

#Opinyon #Opinion #GNBCnews

FOR YOUR INFORMATION. The Opinions or Editorials published in this website are reactions to News Articles published by News Media. This exercise is a manifestation that Democracy and Freedom of Expression in the Philippines exists. However, the accuracy and the authenticity of the News Articles published by News Media are of their responsibility and is subject to the governing laws of the Philippine Constitution.

Antibodies na lalabanan ang COVID-19, natuklasan ng isang Biotech firm

March 24, 2020

Manila, Philippines – Natuklasan ng isang Biotech firm ang ilang mga antibodies na maaring magamit panlaban sa coronavirus disease.

Ayon sa Regeneron Pharmaceuticals Inc nitong Martes na pipili sila ng top two antibodies na idedevelop bilang “cocktail” treatment.

Plano din ng kumpanya na mag mass produce nito bandang kalagitnaan ng Abril ngayong taon.

Matatandaang nakipagpartner ang Regeneron nitong Pebrero sa U.S. Department of Health and Human Services para gumawa ng coronavirus treatment kung saan magpopokus sila sa monoclonal antibodies.

Tinetest din ng kumpanya ang rheumatoid arthritis drug, Kevzara, kasama ang partner nito na Sanofi SA bilang panlaban sa virus. 

Ulat mula Reuters

SOURCE/S
Antibodies na lalabanan ang COVID-19, natuklasan ng isang Biotech firm